{"filings":[{"id":2189716,"accession_number":"0001193125-26-344666","cik":1489993,"company_name":"Mobia Medical, Inc.","ticker":"MOBI","form_type":"8-K","filed_at":"2026-08-11T20:12:00+00:00","items":["2.02","9.01"],"status":"ready","headline":"Mobia Medical Q2 revenue $13.5M (+102% YoY), net loss $21.0M; FY26 guide $54-56M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $13.5M vs $6.7M in Q2 2025, up 102%; gross margin 83.2% vs 82.3%.","Net loss $21.0M ($1.10/share) vs $10.5M loss ($12.44/share) in prior year; per-share drop reflects IPO share conversion.","Cash and equivalents $177.1M as of June 30, 2026; IPO closed May 2026 with ~$134.0M net proceeds.","FY2026 revenue guidance $54-56M, implying 69-75% growth over 2025.","Published two-year VNS-REHAB follow-up data in Neurology; appointed Myriam Curet, M.D. and Reza Zadno, Ph.D. to board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":428124972.47999996,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2026760,"accession_number":"0001193125-26-330853","cik":1489993,"company_name":"Mobia Medical, Inc.","ticker":"MOBI","form_type":"8-K","filed_at":"2026-08-03T21:20:02+00:00","items":["5.02"],"status":"ready","headline":"Mobia Medical appoints Dr. Myriam Curet to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 7 to 8 members; Dr. Curet appointed as Class II director effective July 30, 2026.","Dr. Curet retired in March 2026 as EVP and Chief Medical Officer of Intuitive Surgical (ISRG) after 20+ years.","She also serves on boards of Inspire Medical (INSP) and Stereotaxis (STXS); previously on Nektar Therapeutics (NKTR).","Board determined she qualifies as independent under SEC and Nasdaq rules; no committee assignments yet.","Will receive standard non-employee director compensation; Mobia expects to enter indemnification agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":428124972.47999996,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1664517,"accession_number":"0001193125-26-304763","cik":1489993,"company_name":"Mobia Medical, Inc.","ticker":"MOBI","form_type":"8-K","filed_at":"2026-07-15T20:11:08+00:00","items":["5.02"],"status":"ready","headline":"Mobia Medical appoints Reza Zadno, Ph.D. to board, expands to 7 members","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 6 to 7; Dr. Zadno appointed as Class III director, term through 2029 annual meeting.","Dr. Zadno is independent and will serve on Compensation Committee; Dr. Harrington resigned from that committee.","Previously CEO of PROCEPT BioRobotics (PRCT) and Avedro (now part of Glaukos, GKOS).","Will receive standard non-employee director compensation; no related-party transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":428124972.47999996,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":15644,"accession_number":"0001628280-26-033685","cik":1489993,"company_name":"Mobia Medical, Inc.","ticker":"MOBI","form_type":"8-K","filed_at":"2026-05-11T21:29:55+00:00","items":["5.03","9.01"],"status":"ready","headline":"Mobia Medical completes IPO, adopts amended charter with classified board and exclusive forum provisions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["IPO closed May 11, 2026; authorized common stock increased to 950M shares; 50M shares of undesignated preferred stock authorized.","Board classified into three classes with staggered three-year terms; directors removable only for cause with 2/3 supermajority vote.","Stockholder action by written consent eliminated; advance notice required for director nominations and proposals.","Exclusive forum: Delaware Chancery for internal corporate claims; federal courts for Securities Act claims.","Amended and restated bylaws effective concurrently with charter; procedures for stockholder proposals and nominations established."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":428124972.47999996,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}